Novel MRI pattern found in children with myelin oligodendrocyte glycoprotein (MOG) antibodies

Researchers in Argentina have identified a novel neuroimaging pattern in children with myelin oligodendrocyte glycoprotein (MOG)-associated disorders (MOGAD).

Antibodies against MOG are found in more than 30% of children with a first demyelinating clinical event, according to Dr Silvia Tenembaum of the National Pediatric Hospital Dr Juan P Garrahan, in Buenos Aires, Argentina. Neuroimaging findings can vary widely among patients with MOGAD.

To better characterize MOG-related lesions, Dr Tenembaum and colleagues reviewed imaging data from 53 children with MOGAD treated at their institution. The goal was to determine the frequency and distribution of a novel neuroimaging feature, namely large inflammatory lesions with cystic changes.

Ology Medical Education is a global provider of independent medical education. Its mission is to provide healthcare professionals with high-quality, trusted medical information with the aim of helping optimize patient care.

No responsibility is assumed by Ology Medical Education for any injury and/or damage to persons or property through negligence or otherwise, or from any use or operation of any methods, products, instructions, or ideas contained in the material herein. Because of rapid advances in the medical sciences, Ology Medical Education recommends that independent verification of diagnoses and drug dosages should be made. The opinions expressed do not reflect those of Ology Medical Education or the sponsor. Ology Medical Education assumes no liability for any material contained herein.